ALIBERTI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.988
EU - Europa 928
AS - Asia 856
AF - Africa 20
OC - Oceania 9
SA - Sud America 5
Totale 3.806
Nazione #
US - Stati Uniti d'America 1.980
SG - Singapore 441
CN - Cina 366
IE - Irlanda 338
FI - Finlandia 273
DE - Germania 91
IT - Italia 73
RU - Federazione Russa 48
GB - Regno Unito 36
SE - Svezia 30
CZ - Repubblica Ceca 21
IN - India 18
NG - Nigeria 18
AU - Australia 8
CA - Canada 8
HK - Hong Kong 7
JP - Giappone 7
IL - Israele 6
NL - Olanda 6
PH - Filippine 5
FR - Francia 4
ID - Indonesia 3
BR - Brasile 2
BY - Bielorussia 2
KE - Kenya 2
PE - Perù 2
AR - Argentina 1
AT - Austria 1
GR - Grecia 1
KR - Corea 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TR - Turchia 1
UA - Ucraina 1
Totale 3.806
Città #
Ashburn 470
Boardman 461
New York 361
Shanghai 346
Dublin 338
Singapore 327
Helsinki 273
Los Angeles 100
Seattle 67
Chandler 49
Moscow 41
Phoenix 41
Santa Clara 29
Wilmington 20
Benin City 18
Brno 17
London 17
Pune 14
Lawrence 10
Princeton 10
Hangzhou 7
Munich 7
San Mateo 7
Shijiazhuang 7
Cardiff 6
Milan 6
Naples 6
Sydney 6
Tel Aviv 6
Casal di Principe 5
Falkenstein 5
Gunzenhausen 5
Leawood 5
Wanchai 5
Amsterdam 4
Ann Arbor 4
Cagayan de Oro 4
Olomouc 4
Paris 4
Reggio Calabria 4
Southwark 4
Andover 3
Cagliari 3
Catania 3
Dolianova 3
Frankfurt am Main 3
Guildford 3
Jember 3
Montecassiano 3
Siena 3
St Petersburg 3
Asagayakita 2
Daiba 2
Etobicoke 2
Houston 2
Johnson City 2
Kentville 2
Lima 2
Minsk 2
Nairobi 2
Ottawa 2
Ragusa 2
San Francisco 2
Sarnthein 2
Shenzhen 2
São Paulo 2
Turin 2
Verona 2
Ankara 1
Belgrade 1
Brisbane 1
Brooklyn 1
Cambridge 1
Camden 1
Castellammare di Stabia 1
Clifton 1
Concepción del Uruguay 1
Council Bluffs 1
Cupertino 1
Des Moines 1
Eygelshoven 1
Ferrara 1
Florence 1
Genoa 1
Grimsby 1
Gujrat 1
Heeten 1
Hong Kong 1
Lexington 1
Matsuyama 1
Mumbai 1
Orleans 1
Portici 1
Qingdao 1
Redwood City 1
Rozzano 1
Sankt Augustin 1
Saratov 1
Sassari 1
Seoul 1
Totale 3.216
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 58
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 58
COVID-19 in Immunocompromised Patients: A Systematic Review 45
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 40
Community-acquired pneumonia 34
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 34
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 32
Mapping the human genetic architecture of COVID-19 31
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 28
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 27
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 26
How to Identify Causes and Predisposing Factors in Bronchiectasis 25
Cardiovascular Complications in Community-Acquired Pneumonia 24
COVID-19 in lung transplant recipients: A case series from Milan, Italy 24
Respiratory failure in COVID-19: a patient's perspective and clinical cases 23
Cardiovascular side-effects of common antibiotics 23
Post-COVID-19 sequelae 23
100 years of respiratory medicine : Pneumonia 23
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 22
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 21
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 21
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 21
Treatable traits in interstitial lung diseases: a call to action 20
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 20
Antibiotics for lung disease and cancer 20
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 20
Comparison of different conditions for DNA extraction in sputum - a pilot study 19
A 13-year-old female with shortness of breath and pleuritic chest pain 19
COVID-19 multidisciplinary high dependency unit: the Milan model 19
Pneumonia: how important are local epidemiology and smoking habits? 19
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 19
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 19
What is the best technique to extract bacterial DNA from sputum? 19
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 18
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 18
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 18
Quando ospedalizzare un paziente con polmonite acquisita in comunità 18
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 17
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 17
Multidrug-resistant pathogens in patients with pneumonia coming from the community 17
Treatment in exacerbations of the upper and lower airways 17
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 17
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 17
A 61-year-old female with chronic cough and purulent sputum 16
Quinine treatment in severe Plasmodium falciparum malaria in children. A Holter monitoring 16
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 16
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 16
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 16
Chlamydia pneumoniae and Mycoplasma pneumoniae 15
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 15
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 15
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 15
Neutrophil elastase in bronchiectasis 15
Vaccinations: What's best? 15
Acute exacerbation of COPD: application of evidence-based guidelines 15
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 15
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 15
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 14
Towards tuberculosis elimination: an action framework for low-incidence countries 14
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 14
Acute exacerbations of COPD : application of evidence-based guidelines 14
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 14
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 14
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 14
Protease-Antiprotease Imbalance in Bronchiectasis 14
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 14
A comprehensive approach to lung function in bronchiectasis 14
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 14
Site of care and multidisciplinary approach 14
Diagnosis and Initial Investigation of Bronchiectasis 14
Hospital-acquired pneumonia 14
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 14
Vaccinazione antipneumococcica negli adulti: raccomandazioni della Società italiana di medicina respiratoria (SIMeR) e della Società italiana di igiene, medicina preventiva e Sanità pubblica (SItI)=Pneumococcal vaccination in adults: recommendations from the Italian society of respiratory medicine (SIMeR) and the Italian society of hygiene, preventicve medicine and public health (SItI) 14
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials 13
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis 13
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? 13
What is important for people with NTM? An EMBARC-ELF patient survey 13
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project 13
Mixed Community-acquired Lower Respiratory Tract Infections 13
Acute respiratory failure and severe sepsis in cap : different outcomes? 13
TB elimination : a dream or a reality? Key lessons from the ERS external course in Dubrovnik, Croatia 13
Creatine combined with branched-chain amino acids supplement in speleological practice. A scientific controlled trial 13
Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia 13
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 13
Antimicrobial Therapy in Community-Acquired Pneumonia. 13
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 13
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 13
Bronchiectasis: A pulmonary disease with systemic consequences 13
The biology of pulmonary exacerbations in bronchiectasis 13
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 12
Blood eosinophils predict inhaled fluticasone response in bronchiectasis 12
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 12
Continuous professional development: elevating thoracic oncology education in Europe 12
Get together to increase awareness in bronchiectasisn: a report of the 2nd World Bronchiectasis Conference 12
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel 12
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 12
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 12
Therapeutic Strategies for COVID-19 Lung Disease in Children 12
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 12
Raccomandazioni SIMeR-SITI : vaccinazione antipneumococcica 12
Totale 1.829
Categoria #
all - tutte 47.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 9 0 0 0 1 11 5 5 6 2 1 4
2021/202260 0 1 2 4 0 0 0 3 8 20 17 5
2022/2023595 25 8 19 9 16 5 55 14 43 65 322 14
2023/20243.347 221 157 794 191 171 607 220 92 39 143 295 417
2024/2025199 119 23 40 17 0 0 0 0 0 0 0 0
Totale 4.245